Categories
Events

Agentic AI: Shaping the Business Landscape of Tomorrow

Categories
Events

Agentic AI: Shaping the Business Landscape of Tomorrow

Open Innovator hosted Agentic AI Knowledge Session convened an assembly of distinguished thought leaders, innovators, and industry professionals to delve into the transformative prospects of agentic AI in revamping business practices, fostering innovation, and bolstering collaboration.

The virtual event held on March 21st , moderated by Naman Kothari, underscored the distinctive traits of agentic AI—its proactive and dynamic nature contrasting with the traditional, reactive AI models. The session encompassed engaging panel discussions, startup presentations, and profound insights on how small and medium enterprises (SMEs) can exploit agentic AI to enhance productivity, efficiency, and decision-making capabilities.

Prominent Speakers and Discussion Points:

  • Sushant Bindal, Innovation Partnerships Head at MeitY-Nasscom CoE, steered conversations about nurturing innovation within Indian businesses.
  • Dr. Jarkko Moilanen, Platform Product Head for the Department of Government Enablement in Abu Dhabi, UAE, offered insights into AI’s evolving role within governmental and public domains.
  • Olga Oskolkova, Founder of Generative AI Works, and Georg Brutzer, Agentic AI Strategy Consultant, delved into the long-term implications of agentic AI for commerce and governance frameworks.
  • Shayak Mazumder, CEO of Adya, presented their technology platform, which is instrumental in advancing ONDC adoption in India and simplifying AI integration.
  • Divjot Singh and Rajesh P. Nair, the masterminds behind Speed Tech, showcased their intelligent enterprise assistant aimed at optimizing operations and enhancing decision-making processes.

Overview of the Future of AI in Business

Naman Kothari initiated the session by distinguishing between conventional AI and agentic AI, likening the latter to a proactive participant in a classroom setting. This distinction laid the foundation for an exploration of how AI can transcend automation to facilitate real-time decision-making and collaboration across various industries.

Agentic AI’s Impact on SMEs

A pivotal theme was the substantial benefits that agentic AI can offer to SMEs. Georg Brutzer underscored that SMEs are at disparate levels of digital maturity, necessitating tailored AI approaches. More digitized firms can integrate AI via SaaS platforms, while less digitized ones should prioritize controlled generative AI projects to cultivate trust and understanding. Olga Oskolkova reinforced the importance of strategic AI adoption to prevent resource waste and missed opportunities.

Building Confidence in AI: Education and Strategy

A prevailing challenge highlighted was the need to establish trust in AI within organizational structures. Sushant Bindal advocated for starting with bite-sized AI projects that yield evident ROI, particularly in sectors like manufacturing and logistics where AI can enhance processes without causing disruptions.

Olga Oskolkova placed emphasis on AI literacy, suggesting businesses prioritize employee education on AI’s capabilities, limitations, and ethical ramifications. This approach fosters an environment conducive to learning and helps navigate beyond the hype to derive actual value from AI adoption.

Governance and Ethical Considerations

The increasing integration of AI into business processes has brought to the fore the necessity for robust governance frameworks and ethical considerations. Dr. Jarkko Moilanen spoke on the evolving nature of AI and the imperative for businesses to adapt governance models as AI systems become more autonomous. Balancing machine autonomy with human oversight remains vital for AI to serve as a complementary tool rather than a human replacement.

AI as a Catalyst for Startup and Enterprise Synergy

AI’s role in fostering collaboration between startups and large corporations was another key discussion point. Sushant Bindal pointed out that AI agents can function as matchmakers, identifying supply chain gaps and business needs to facilitate beneficial partnerships. These collaborations can spur innovation and ensure mutual growth for startups and established enterprises.

SaaS Companies and AI’s Evolution

The session touched on the challenges and opportunities SaaS companies face as AI advances. Olga Oskolkova discussed how AI’s transition from basic automation to complex agentic systems would affect business models, suggesting a shift from traditional subscription-based to token-based pricing models tied to output and effectiveness.

Moreover, as AI takes on more sophisticated tasks, businesses must reevaluate their approach to adoption and integration, maintaining human engagement while leveraging AI’s potential.

Startup Showcases: Adya AI and Speed Tech

The session included captivating startup pitches from two innovative companies:

– Adya AI, presented by Shayak Mazumder, showcased their platform’s ability to create custom AI agents using a user-friendly drag-and-drop interface, streamlining data integration and app development. This underscored the potential for agentic AI to boost productivity, innovation, and accessibility.

– Divjot Singh and Rajesh P. Nair introduced Speed Tech’s intelligent enterprise assistant, designed to optimize operations and decision-making. Their product, Rya, demonstrated AI’s ability to enhance customer service and minimize operational costs by addressing challenges such as long wait times and document processing errors.

Concluding Remarks and Key Takeaways

The session concluded with an emphasis on collaboration, innovation, and continuous learning as essential for harnessing agentic AI’s potential. The session encouraged the audience to embrace the evolving AI landscape and recognize the vast potential for business transformation. The speakers collectively highlighted the importance of education, strategy, and collaboration in navigating AI integration successfully. The event left participants with a clear understanding of the profound impact of AI and a call to stay informed, explore emerging opportunities, and drive innovation within the realm of AI.

Categories
Success Stories

Revolutionizing Healthcare: How Moderna and OpenAI’s Partnership is Transforming Medicine with AI

Categories
Success Stories

Revolutionizing Healthcare: How Moderna and OpenAI’s Partnership is Transforming Medicine with AI

In a groundbreaking collaboration, Moderna and OpenAI are revolutionizing the healthcare landscape by utilizing the transformative potential of artificial intelligence. This collaboration represents a major advancement in incorporating AI into Moderna’s operations, with the goal of redefining business and healthcare.

The Genesis of the Partnership

Early in 2023, Moderna, a leader in mRNA technology, and OpenAI, a leader in artificial intelligence, set out to collaborate and expand the realm of healthcare innovation. Since its founding, Moderna has solid data and analytics base and has prioritized digitalization. The company has been using machine learning to improve its business processes and was in a great position to smoothly incorporate generative AI into its operations.

The Launch of mChat

The collaboration started with the creation of mChat, Moderna’s unique ChatGPT instance based on OpenAI’s API. More than 80% of Moderna’s staff members adopted mChat, demonstrating the app’s tremendous success. The organization developed a strong AI culture as a result of this quick acceptance, opening the door for more extensive AI integration.

Embracing ChatGPT Enterprise

Moderna introduced ChatGPT Enterprise, adding improved features including Advanced Analytics, Image Generation, and GPTs, to build on the success of mChat. These tools were integrated into a wide range of company processes, including manufacturing, research, legal, and commercial. Moderna was able to increase productivity and creativity by providing individualized help to its personnel through the use of these AI-powered assistants.

The Transformative Role of AI

The leadership at Moderna believes that AI has the power to fundamentally alter our daily lives. The statement of CEO of Moderna, Stéphane Bancel, comparing the effects of AI to the 1980s, when personal computers were first introduced is an example of the company’s commitment to encorporating AI. Moderna is working towards its ambitious aim to introduce many products over the next few years and plans to have more partnerships like the one with OpenAI in order to maximize the company’s effect on patients.

Driving Automation and Productivity

Since implementing ChatGPT Enterprise, Moderna has installed over 750 GPTs across the enterprise. These AI solutions have increased productivity and automation, allowing the business to more effectively handle challenging issues. The dosage ID GPT is a noteworthy application that assesses the ideal vaccination dosage chosen by the clinical trial team using ChatGPT’s Advanced Data Analytics. dosage ID gives a justification, cites its sources, and creates educational infographics that highlight important results by using standard dosage selection criteria. For late-stage clinical trials, this meticulous review procedure, which is overseen by humans and enhanced by AI, guarantees safety and improves the vaccination dosage profile.

Advancing mRNA Medicines

AI solutions such as ChatGPT further support Moderna’s quest to offer effective mRNA therapeutics. The creation of treatments and vaccinations for a number of illnesses, including one of the most successful COVID-19 vaccines, has already been made possible using the company’s mRNA platform. Moderna is well-positioned to go on its pioneering journey, revolutionizing the way we treat and prevent illnesses using automation and AI-driven insights.

Shared Values and Future Vision

Research-driven innovation is a shared commitment between Moderna and OpenAI. OpenAI CEO Sam Altman commended Moderna for enabling its staff to apply AI to solve challenging issues. This partnership aims to push the limits of what is feasible in order to provide patients in need with a new generation of medications, not merely to take advantage of technology.

Takeaway

The partnership between Moderna and OpenAI is a prime example of how AI has the potential to transform the medical field. Moderna is advancing medical research in ways never seen before by integrating AI tools into every aspect of its business. This collaboration demonstrates how technology can improve people’s health and well-being. Moderna is dedicated to using mRNA therapeutics to have the biggest potential impact on human health as it innovates at the nexus of science, technology, and healthcare.

Source: https://investors.modernatx.com/news/news-details/2024/Moderna-and-OpenAI-Collaborate-To-Advance-mRNA-Medicine/default.aspx